Oversea-Chinese Banking Corp (OCBC)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$577K Buy
+1,480
New +$626K 0.01% 310
2026
Q1
Sell
-584
Closed -$273K 350
2025
Q4
$273K Buy
+584
New +$271K 0.01% 303
2025
Q3
Sell
-2,223
Closed -$852K 344
2025
Q2
$852K Sell
2,223
-521
-19% -$188K 0.02% 217
2025
Q1
$948K Sell
2,744
-400
-13% -$129K 0.03% 229
2024
Q4
$944K Buy
3,144
+221
+8% +$77.2K 0.03% 226
2024
Q3
$1.19M Buy
2,923
+550
+23% +$201K 0.03% 219
2024
Q2
$762K Sell
2,373
-399
-14% -$130K 0.02% 252
2024
Q1
$924K Buy
+2,772
New +$847K 0.03% 224
2023
Q3
Sell
-722
Closed -$219K 397
2023
Q2
$219K Buy
+722
New +$201K 0.01% 308

Other funds holding HCA

Oversea-Chinese Banking Corp (OCBC)'s HCA Position: Q2 2026 in Review

Oversea-Chinese Banking Corp (OCBC) opened a new position in HCA Healthcare (HCA) in Q2 2026: 1,480 shares worth $577K. The stake represents 0.01% of the portfolio and ranks #310 among its holdings. This is a return to the name: Oversea-Chinese Banking Corp (OCBC) previously reported a position in HCA as recently as Q4 2025.

Oversea-Chinese Banking Corp (OCBC) first reported a position in HCA in Q2 2023 and has held it in 9 quarters since. The position peaked at $1.19M in Q3 2024. 909 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Oversea-Chinese Banking Corp (OCBC) held 1,480 shares of HCA Healthcare worth $577K as of Q2 2026.
  • HCA Healthcare was a new Oversea-Chinese Banking Corp (OCBC) position in Q2 2026.
  • HCA Healthcare made up 0.01% of Oversea-Chinese Banking Corp (OCBC)'s portfolio in Q2 2026, its #310 holding.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in HCA Healthcare in Q2 2023 and has held it in 9 quarters since.
  • Oversea-Chinese Banking Corp (OCBC)'s HCA Healthcare position peaked at $1.19M in Q3 2024.
  • 909 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q2 2026, filed 11 Aug 2026.